HF

Huichen Feng

Research Scientist at NSABP Foundation Inc.

Huichen Feng is a highly experienced research scientist currently working at NSABP Foundation Inc. since June 2014, following a role as a research associate at the University of Pittsburgh from April 2006 to June 2014. Prior experience includes a position as a research assistant at the University of Hong Kong from March 2005 to February 2006 and as a research and teaching assistant at Harbin Medical University from September 1995 to August 1997. Huichen Feng holds a PhD in Cancer Biology from The University of Hong Kong, a Master's degree in Medical Genetics from Harbin Medical University, and a Bachelor's degree in Biology and Computer Science from Northeast Agricultural University.

Location

Pittsburgh, United States

Links

Previous companies


Org chart


Teams


Offices


NSABP Foundation Inc.

Partners in Cancer Research… The NSABP Foundation is a not-for-profit academic research organization with a nearly 60-year history of conducting ground-breaking research studies in breast and colorectal cancer. Our goal is to improve outcomes for cancer patients via improved therapeutic and prevention modalities. Over the past 15 years we have established full-service capabilities to conduct independently funded international research with the private sector to evaluate promising new agents and now offer a wide range of capabilities, from pre-clinical research through phase III clinical trials focused on biomarker-driven studies. In its history the NSABP has enrolled more than 110,000 women and men in clinical trials in breast and colorectal cancer. We have research sites at nearly 700 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, and Ireland. At those sites and their satellites, about 5000 physicians, nurses, and other medical professionals conduct NSABP treatment and prevention trials. The NSABP Foundation, located at Nova Place in Pittsburgh, Pennsylvania, carries on the legacy of the National Surgical Adjuvant Breast and Bowel Project in clinical studies done in partnership with industry.


Employees

51-200

Links